And-1 Coordinates with the FANCM Complex to Regulate Fanconi Anemia Signaling and Cisplatin Resistance
- 22 July 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (18) , 3249-3262
Abstract
The Fanconi anemia (FA) pathway is essential for repairing DNA interstrand crosslinks (ICL). ICLs induce stalled DNA replication forks and trigger activation of the FA pathway by promoting recruitment of the FANCM/FAAP24/MHF complex to ICL sites. Given that stalled replication forks are proximal to ICL sites, fork-associated proteins may coordinate with FA factors to rapidly sense ICLs for activation of FA signaling. Here we report that And-1, a replisome protein, is critical for activation of the FA pathway by sensing ICL-stalled forks and recruiting the FANCM/FAAP24 complex to ICLs. In response to ICLs, And-1 rapidly accumulated at ICL-stalled forks in a manner dependent on ataxia telangiectasia and Rad3-related protein–induced phosphorylation at T826. And-1 phosphorylation triggered an intramolecular change that promoted the interaction of And-1 with FANCM/FAAP24, resulting in recruitment of the FANCM/FAAP24 complex to ICLs. Furthermore, p-T826 And-1 was elevated in cisplatin-resistant ovarian cancer cells, and activated And-1 contributed to cisplatin resistance. Collectively, these studies elucidate a mechanism by which And-1 regulates FA signaling and identify And-1 as a potential target for developing therapeutic approaches to treat platinum-resistant ovarian cancer. Significance: This work shows that phosphorylation of And-1 by ATR activates Fanconi anemia signaling at interstrand crosslink–stalled replication forks by recruiting the FANCM/FAAP24 complex, revealing And-1 as a potential therapeutic target in cancer.Keywords
All Related Versions
Funding Information
- NIH (CA247684, CA258357, CA184717)
This publication has 53 references indexed in Scilit:
- Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathwayGenes & Development, 2012
- Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatinMolecular Cancer, 2012
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- A Histone-Fold Complex and FANCM Form a Conserved DNA-Remodeling Complex to Maintain Genome StabilityMolecular Cell, 2010
- MHF1-MHF2, a Histone-Fold-Containing Protein Complex, Participates in the Fanconi Anemia Pathway via FANCMMolecular Cell, 2010
- The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link RepairScience, 2009
- Fanconi anemia and its diagnosisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
- Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapyBritish Journal of Cancer, 2007
- Mcm10 and And-1/CTF4 recruit DNA polymerase α to chromatin for initiation of DNA replicationGenes & Development, 2007
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003